Jarrard Inc. Strengthens Healthcare Strategy with New Talent
Jarrard Inc. Enhances Healthcare Consulting Services
Jarrard welcomes five new colleagues to strengthen client partnerships across its practices
In a significant move to bolster its expertise, Jarrard, a prominent healthcare strategic communications and change management firm, has recently added five new professionals to its team. This expansion primarily aims to enhance the firm's proficiency in philanthropy, public affairs, graphic design, and advisory services.
Leading this talented group is Senior Vice President Melinda Church, who comes to Jarrard with an impressive background in philanthropy and advancement communications. This addition is set to enrich Jarrard's work with healthcare organizations that are engaged in transformational giving and sustainable investment strategies.
"The role of philanthropy is essential for the survival and improvement of healthcare in the U.S.," remarked Jarrard President and Co-Founder Anne Hancock Toomey. "Melinda's extensive experience in fundraising and institutional strategy will empower our clients to connect more effectively with donors and inspire trust and generosity. We are excited to welcome her to our team, enhancing this crucial area of our service offerings."
Melinda Church brings a wealth of knowledge from advising nearly 150 clients globally on philanthropic strategies, campaign developments, and donor communications. Prior to joining Jarrard, she successfully led the strategic communications practice at Grenzebach Glier and Associates and founded her own philanthropy communications firm. Her previous roles included senior communications positions at notable institutions such as The Ohio State University, the University of Chicago, and the University of Virginia, where she spearheaded multi-billion dollar fundraising campaigns.
Another noteworthy addition to the Jarrard team is Of Counsel Rose Glenn, a nationally acknowledged healthcare communications leader. With four decades of experience in her field, Rose has a rich background in guiding strategy and leading brand transformations within health organizations. Recently, she served as the chief communications and marketing officer for Michigan Medicine and contributed significantly to the success of Henry Ford over 18 years in senior vice president roles.
"Rose has dedicated her career to assisting health organizations during complex transformations. Her valuable perspective during challenging times is a significant asset for our clients and internal team alike," Toomey commented.
Welcoming New Team Members at Jarrard
Susan Feeney, Associate Vice President, Public & Community Health Systems, also joins Jarrard with over 20 years of experience in strategic communications and public affairs. Susan has led national campaigns and initiatives for hospitals and healthcare providers, recently serving as director of member services at the Alliance for Recovery Care.
Meredith Sepahani, Senior Graphic Designer, brings a wealth of experience in digital marketing and branding. Her past roles include managing digital marketing efforts at California State University and leading creative strategies for reputable brands such as L'Oreal's The Body Shop and Red Hat.
Carrie Douglas, Senior Advisor of The Advisor Group, enhances Jarrard’s offerings with her deep expertise in healthcare communications and public affairs. Before joining Jarrard, Carrie worked on national campaigns for AmeriCorps and the U.S. Department of Health and Human Services, contributing to initiatives aimed at improving public health outcomes.
About Jarrard Inc.
Jarrard is a specialized healthcare consulting firm dedicated to supporting leaders through challenging and transformative moments. By harnessing the power of communications, marketing, and political strategy, Jarrard helps its clients achieve their crucial goals. With operations launched in 2006, the firm has partnered with over 1,800 clients across the United States, focusing on change management, advocacy, and strategic positioning. Jarrard Inc. is a proud division of Chartis, a leading healthcare advisory firm. For further information, visit jarrardinc.com or connect via LinkedIn.
Frequently Asked Questions
What is Jarrard Inc. known for?
Jarrard Inc. is recognized for its expertise in healthcare strategic communications and change management.
Who joined Jarrard Inc. recently?
Five new professionals have joined Jarrard, including experts in philanthropy, public affairs, and graphic design.
What role does philanthropy play in healthcare?
Philanthropy is increasingly vital for the sustainability and advancement of healthcare organizations.
How does Jarrard Inc. support its clients?
Jarrard provides strategic guidance encompassing communications, marketing, and advocacy to help clients meet their challenges.
What is the background of Melinda Church?
Melinda Church has extensive experience in philanthropic strategy and has advised numerous clients globally on fundraising initiatives.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.